Biolife stock.

BANNOCKBURN, Ill., March 27, 2023--BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of its 200th plasma donation center in the United ...WebIn today’s fast-paced world, personal health tracking has become increasingly important. With the rise of digital technology, there are now numerous apps available to help individuals monitor and improve their well-being.Dividends. A high-level overview of BioLife Solutions, Inc. (BLFS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Get the latest BioLife Sciences Inc. (BLFE) stock news and headlines to help you in your trading and investing decisions. Discover Biolife from Goldwell. Within our collection of perming solutions from Goldwell, we stock the Biolife 2 Tinted/bleached hair solution, the Biolife 1 Normal/Fine solution and the Biolife Resistant / Coarse hair treatment. So whatever kind of hair your client has, be sure to have the perming solutions available for each and every variable!

Biolife Sciences Inc (BLFE) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time Key Data Bid Price and Ask Price The bid & ask refers to the price …According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.

BOTHELL, WA— January 12, 2015 — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues (“BioLife” or the “Company”), today announced preliminary revenue for the fourth quarter …Dec 4, 2023 · Biolife Solutions Inc (NASDAQ:BLFS) has a beta value of 1.60 and has seen 2.24 million shares traded in the last trading session. The company, currently valued at $596.91M, closed the last trade at $13.25 per share which meant it gained $0.88 on the day or 7.11% during that session. The BLFS stock ...

biolife sciences inc. biolife sciences inc. 0.00 ‎-11.11% 0.0004Dec 18, 2022 · Conestoga Capital Advisors highlighted stocks like BioLife Solutions, Inc. (NASDAQ:BLFS) in its Q3 2022 investor letter. Headquartered in Bothell, Washington, BioLife Solutions, Inc. (NASDAQ:BLFS ... View BioLife Solutions, Inc BLFS investment & stock information. Get the latest BioLife Solutions, Inc BLFS detailed stock quotes, stock data, Real-Time ECN, …BioLife Solutions, Inc. : News, information and stories for BioLife Solutions, Inc. | Other OTC: | Other OTCBioLife Sciences Inc. (“BioLife" or the "Company") (OTCPK: BLFE) specializes in moving innovative products from the lab or small-scale production. BLFE : 0.0001 (unch) BioLife Sciences Retains GS Whitney & Co for Corporate Relations Globe Newswire - Wed Aug 3, 2022. HENDERSON, NV, Aug. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife ...

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced ...

BioLife Solutions, Inc. (NasdaqCM:BLFS) entered into a definitive agreement and plan of merger to acquire Global Cooling, Inc. for approximately $270 million on March 19, 2021. Under the terms of the transaction, BioLife will issue 6.65 million shares of its common stock. The consideration also include the assumption of $8.7 million debt.Web

BioLife Solutions, Inc. announced that it has received $10.374976 million in funding from Casdin Capital, LLC. 10-19. CI. Lake Street Adjusts Price Target on BioLife Solutions to $25 From $34, Maintains Buy Rating. 08-09. MT. Transcript : BioLife Solutions, Inc., Q2 2023 Earnings Call, Aug 08, 2023. 08-09.WebIf you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.BioLife Solutions Return On Equity is currently at (0.23)%. Return on Equity or ROE tells BioLife Solutions stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing BioLife Solutions profitability or the management effectiveness given the capital invested by the shareholders. ROE shows …BioLife Solutions Trading Up 2.5 %. NASDAQ BLFS traded up $0.33 on Monday, hitting $13.58. 44,504 shares of the stock were exchanged, compared to its average volume of 403,529. The company’s 50 ...WebBioLife Solutions Debt to Equity is currently at 0.06%. Debt to Equity is calculated by dividing the Total Debt of BioLife Solutions by its Equity. If the debt exceeds equity of BioLife. then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of …

According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.1) Consists of 10,735,334 shares of common stock being registered for resale by selling stockholders. The shares consist of (i) 611,683 shares issued in October 2020 in connection with the registrant’s acquisition of SciSafe Holdings, Inc., which had not been previously registered, (ii) 2,956,679 shares held by Casdin Partners Master Fund, LP (“Casdin”) which were acquired in various ...BOTHELL, Wash., Jan. 5, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction ...WebBiolife Sciences story: Single Use Bio Processing System Market Analysis,Global Key Company Profiles,Types,Applications and Forecast To 2027 The Bisouv Network The Bisouv Network and other headlines for Biolife SciencesOctapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disorders

BOTHELL - BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ('CGT') and broader biopharma markets, today announced the launch of Ultraguard, the first ever non-toxic, non-hazardous and non-flammable -70-degreeC phase change material ('PCM'), for ultra-low temperature (ULT) protection.

Historical daily share price chart and data for BioLife Solutions since 1992 adjusted for splits and dividends. The latest closing stock price for BioLife Solutions as of December 01, 2023 is 13.25.. The all-time high BioLife Solutions stock closing price was 140.00 on December 15, 1992.; The BioLife Solutions 52-week high stock price is 26.89, which is 102.9% …WebBOTHELL, Wash., April 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has launched a new line of high capacity controlled rate freezers (HCRF), with an …The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.BioLife stock has skyrocketed over 280% since hitting a March low of 7.37 in the coronavirus stock market crash. Since retaking its 50-day line in May, BioLife stock has found support at that ...WebDec 1, 2023 · Dividends. A high-level overview of BioLife Solutions, Inc. (BLFS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. B. Riley FBR analyst Marc Wiesenberger resumed coverage of BioLife stock with a Buy rating and a price target of $27 per share, representing a 94.6% premium to Thursday's closing price. As cell ...Macquarie Group Ltd. now owns a total of 68,317 shares of BioLife Solutions’ stock after purchasing an additional 12,644 shares during the period. At the end of the most recent quarter, Macquarie Group Ltd.’s stake in BioLife Solutions was valued at approximately $1,486,000. This amounted to 0.16% ownership of the medical equipment provider ...BLFS Stock 12 Months Forecast. $23.25. (128.61% Upside) Based on 6 Wall Street analysts offering 12 month price targets for BioLife Solutions in the last 3 months. The average price target is $23.25 with a high forecast of $26.00 and a low forecast of $20.00. The average price target represents a 128.61% change from the last price of $10.17.Overview News BioLife Solutions Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-2.37 Market Cap 557.24 M …

Stock. Governance. Analyst Coverage. Company. Company. Company. Press Releases. Events. Leadership. Board of Directors. Scientific Advisory Board. Quality Management System. Patents. ... Prior to BioLife’s acquisition of SciSafe, Inc. in October 2020, Mr. Richardson was the President and Founder of SciSafe, Inc. from 2010 to 2020, …

Exact matches only . Search in title. Search in title

BioLife Solutions Price to Earnings To Growth is currently at 63.20 X. PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a …Dec 1, 2023 · BioLife Solutions (NASDAQ:BLFS) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock?We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking. BioLife Solutions is a bioproduction company that develops, manufactures, and sells biopreservation media, thawing products, and shipping containers for cell and gene …Chief Quality Officer Of Biolife Solutions Trades $760K In Company Stock. (Benzinga) Sep-20-21 08:00AM. BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors. (PR Newswire) BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings ...Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest BioLife Solutions Inc (BLFS) real-time quote, historical performance, charts, and other financial information to help you make ...View the latest BioLife Sciences Inc. (BLFE) stock price, news, historical charts, analyst ratings and financial information from WSJ. BIOLIFE SOLUTIONS INC NEW COM STK (DE); BioLife Solutions, Inc. BioLife Solutions, Inc. View SEC Filings ... Stock Lookup. Enter stock name: use * for wildcard.BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ...BioLife Solutions Trading Up 2.5 %. NASDAQ BLFS traded up $0.33 on Monday, hitting $13.58. 44,504 shares of the stock were exchanged, compared to its average volume of 403,529. The company’s 50 ...WebBioLife Solutions, Inc. (BLFS) Stock Price, Quote & News - Stock Analysis BioLife Solutions, Inc. ( BLFS) NASDAQ · USD 11.99 -0.06 (-0.50%) Oct 16, 2023, 10:35 …BioLife Solutions Inc (NASDAQ:BLFS). 12.77. Delayed Data. As of Nov 17. +0.81 / + ... Most stock quote data provided by BATS. Market indices are shown in real ...

Biolife Solutions Inc (NASDAQ:BLFS) has a beta value of 1.60 and has seen 2.24 million shares traded in the last trading session. The company, currently valued at $596.91M, closed the last trade at $13.25 per share which meant it gained $0.88 on the day or 7.11% during that session. ... The BLFS stock price is -102.94% off its 52-week high ...WebBioLife Solutions Trading Up 2.5 %. NASDAQ BLFS traded up $0.33 on Monday, hitting $13.58. 44,504 shares of the stock were exchanged, compared to its average volume of 403,529. The company’s 50 ...BLFS. BioLife Solutions, Inc. 11.83. +1.05. +9.74%. The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of ...BioLife Solutions Trading Up 2.5 %. NASDAQ BLFS traded up $0.33 on Monday, hitting $13.58. 44,504 shares of the stock were exchanged, compared to its average volume of 403,529. The company’s 50 ...Instagram:https://instagram. mlmnplatinum stocks listpersonal loan for manufactured homebest forex trade platform Nov 28, 2023 · Stock analysis for Biolife Sciences Inc (BLFE:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. BioLife Solutions, Inc. (“BioLife”, “us”, “we”, “our”, or the “Company”) is a developer, manufacturer, and supplier of a portfolio of bioproduction tools and services including proprietary biopreservation media, automated cell processing fill machines, closed system cryogenic vials, human platelet lysate (“hPL”) growth ... 4 dollar stocksfpe stock BioLife Solutions Trading Up 2.5 %. NASDAQ BLFS traded up $0.33 on Monday, hitting $13.58. 44,504 shares of the stock were exchanged, compared to its average volume of 403,529. The company’s 50 ... how to get tmj botox covered by insurance The stock soared from a split-adjusted IPO price of $1.50 per share to $106.69 per share on Dec. 10, 1999. From there, it proceeded to fall 96% until it bottomed on Sept. 28, 2001, at $5.97 per share.B. Riley FBR analyst Marc Wiesenberger resumed coverage of BioLife stock with a Buy rating and a price target of $27 per share, representing a 94.6% premium to Thursday's closing price. As cell ...